Location: Home
  • search
  • go
  • Relate News
  • 7/3/2025Akeso Launches Clinical Trials for First Bispecific ADC
  • 7/3/2025Cloudbreak Pharma Debuts on HKEX, Raising HK$612 Million in IPO
  • 7/3/2025Belief BioMed Unveils 4-Year Follow-Up Data for Hemophilia B Gene Ther...
  • 7/3/2025CTTQ's Homegrown rFVIIa Wins NMPA Approval for Bleeding Disorders
  • 7/3/2025Hengrui Medicine Gains NMPA Approval for Novel Dry Eye Treatment SHR80...
  • 7/3/2025Eli Lilly's Tirzepatide Approved in China for Treatment of Obstructive...
  • 7/3/2025AbbVie's Venclexta Approved in China for Second-Line Treatment of del1...
  • 7/3/2025Vaccine Sales Collapse in China as MNCs Struggle with Local Competitio...
  • 7/2/2025Biokin's Iza-bren Achieves Primary Endpoint in Phase III Trial for Nas...
  • 7/2/2025Simcere's Suvemcitug Approved in China for Platinum-Resistant Ovarian ...
  • 7/2/2025China Grants Conditional Approval to Bebetter Medicine's Ifupinostat f...
  • 7/2/2025NMPA Grants Marketing Approval to GeneScience's Firsekibart for Acute ...
  • 7/2/2025Betta's Tibremciclib Approved in China for Advanced HR+/HER2– Breast ...
  • 7/2/2025InventisBio Launches First Phase III Trial of TYK2 Inhibitor D‑2570 i...
  • 7/2/2025HanchorBio and Henlius Ink Major Licensing Deal for I/O Candidate HCB1...
  • 7/2/2025China Issues Technical Guidance for Clinical Resistance Studies of Ant...
  • 7/2/2025China to Eliminate CD Submission Requirement for Clinical Trial Databa...
  • 7/2/2025API China 2025 Ends with High Attendance and Global Industry Participa...
  • 7/2/2025Medical Advances Soar With APAC's Clinical Trial Growth (BioSpectrum)
  • 7/2/2025FDA's Crackdown and China's Dealmaking: Warning Signs or Business as U...
  • 7/1/2025China Launches Landmark Measures to Boost Innovative Drug Industry, Se...
  • 7/1/2025BeOne Launches Phase III Trial Comparing Subcutaneous and Intravenous ...
  • 7/1/2025Tracking the Crossroads of Policy, Innovation, and Global Biotech Inve...
  • 7/1/2025Mabwell Announces License Deal with Qilu for Albipagrastim alfa for I...
  • 7/1/2025Hutchmed Receives Chinese Approval for Lung Cancer Drug Combo, Trigger...
  • 7/1/2025Biological E and China's Recbio Partner to Bring HPV9 Vaccine to India...
  • 7/1/2025CDE Seeks Feedback on Draft Guidelines for Pharma Changes in Cell Ther...
  • 7/1/2025NHSA Seeks Public Input on 2025 Drug Reimbursement and Innovation List...
  • 7/1/2025Healthgen Biotech IPO Approved, First STAR Market Biopharma Case Since...
  • 7/1/2025Adagene Secures Up to $25 Million from Sanofi to Advance SAFEbody Pipe...
  • Page:5/779 Total number of articles:23361: [First][<<] [3] [4] [5] [6] [7] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group